Biologics and Bronchienctasis

Biologics are therapies made from living organisms or their components—such as proteins, cells, or bacteria. 

Unlike traditional drugs made through chemical synthesis, biologics are developed using biotechnology. This allows them to target disease processes more precisely, often resulting in better outcomes and fewer side effects for certain conditions.

🧬 Learn more about how biologics are made and approved from the U.S. Food and Drug Administration (FDA).

You’ve Probably Already Had a Biologic

If you’ve received a vaccine, you’ve already experienced a biologic therapy in action. Vaccines for:

• Influenza
• Hepatitis B
• HPV
• COVID-19
  
  

…are all considered biologics. These treatments work by stimulating your immune system to recognize and respond to specific pathogens. According to the Centers for Disease Control and Prevention (CDC), vaccines are among the most effective tools for preventing infectious disease.

A Personal Note: How the HPV Vaccine Changed My Perspective

More than 25 years ago, I had a hysterectomy following a diagnosis of cervical carcinoma in situ caused by HPV. At that time, the HPV vaccine didn’t exist. Today, it gives me peace of mind knowing that my grandchildren are protected against this cancer-causing virus, thanks to the development of preventive biologics.

📖 Read more about the HPV vaccine’s role in cancer prevention from the National Cancer Institute.


Biologics in Chronic Illness Care

Biologics aren’t just for disease prevention—they’re also used to treat a variety of chronic inflammatory and autoimmune conditions, including:

• Asthma and other respiratory illnesses
• Rheumatoid arthritis and psoriatic arthritis
• Psoriasis and atopic dermatitis
• Crohn’s disease and ulcerative colitis
• Certain types of cancer
  
  

These treatments work by modulating immune pathways, such as blocking interleukins (IL-4, IL-5, IL-13), IgE, or TNF-alpha—key culprits in chronic inflammation and tissue damage.


Are Biologics Being Studied for Bronchiectasis?

Yes—and that’s where it gets exciting. While no biologics are currently FDA-approved specifically for bronchiectasis, researchers are exploring their potential role in managing bronchiectasis with asthma, allergies, or eosinophilic inflammation—a common combination in clinical practice.

Biologics currently being studied or used for off-label treatments have shown promising results in small studies and case reports involving:

• Asthma–bronchiectasis overlap syndrome (ABOS)
• Allergic bronchopulmonary aspergillosis (ABPA)
  
  

Patients with these conditions may experience:

• Fewer exacerbations
• Improved lung function
• Better quality of life
  
  

🤔 Are Biologics Safe?

While biologics are powerful, they’re also extensively tested. As with any treatment, side effects are possible—but today’s biologics are held to high safety standards. In fact, biologics are often used when standard treatments fail or when precision is needed to avoid broader immune suppression.

Biologics Are Already Changing Lives

From vaccines to advanced immune therapies, biologics are transforming how we prevent, treat, and manage disease. And while they may sound “new” or “intimidating,” they’ve been part of mainstream medicine for decades—and they’re only getting better.
If you live with bronchiectasis, asthma, or a chronic inflammatory condition, biologics may be an option worth discussing with your care team—especially if standard therapies aren’t enough.

#BiologicsExplained #BronchiectasisCare #FutureOfMedicine #AsthmaOverlap #ChronicInflammation